Skip to main content

Table 1 Cyclins D2 and D3 expression in de novo CD5 + and CD5 DLBCLs

From: De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression

  De novo CD5+DLBCLs CD5DLBCLs P
Cyclin D2 50/51 (98%) 14/51 (28%) P < 0.0001
Cyclin D3 18/51 (35%) 24/51 (47%) P = 0.23